Back A A A Font Size Receive E-mail Alerts Press Releases

MicroPort® Signs Strategic Agreement with Wuhan Asian Industrial

[2018-02-22] 

Shanghai, China –Shanghai MicroPort Medical (Group) Co., Ltd. ("MicroPort®") recently reached a strategic agreement with Wuhan Asian Industrial Co, Ltd. ("Wuhan Asian Industrial") at a meeting of Innovative Cooperation Under the New Environment and New Opportunities in Shanghai. MicroPort® Chairman & Chief Executive Officer Dr. Zhaohua Chang and Wuhan Asian Industrial Chairman & General Manager Junming Xie signed the agreement on behalf of the two companies at the headquarter of MicroPort.
 
MicroPort® and Wuhan Asian Industrial reached the strategic agreement in order to cooperate in the research and development of new technology and new product in the medical device industry. The two parties will strengthen their cooperation in clinical study and technology to better foresee the industry development trend and identify unsatisfied clinical needs. At the same time, the bilateral cooperation will help promoting the development of the industrialization projects. According to the agreement, the relatively mature techniques that Wuhan Asian Industrial acquired from its clinical study will be shown to and evaluated by Microport®, which will then provide its assessment advice on industrialization. The two parties will actively explore and implement possible industrialization projects by sharing resources and leveraging complementary advantages in R&D and clinical study.
 
MicroPort Scientific Corporation (the "Group") is a leading medical device company with business focusing on innovating, manufacturing, and marketing high-quality and high-end medical devices globally. With a diverse portfolio of products now being used at an average rate of one for every 15 seconds in thousands of major hospitals around the world, the Group maintains world-wide operations in a broad range of business segments including Cardiovascular, Orthopedic, Electrophysiological, Endovascular, Neurovascular, Surgical, Diabetes Care and Endocrinal Management, and others. Wuhan Asian Industrial is a medical device company with business focusing on research, development and production. It also owns several renowned cardiology specialized hospitals in China with Wuhan Asia Heart Hospital (WAHH) being the first non-profit private-owned one. WAHH's annual surgical operation amount has been top 1 in Hubei Province and among the top three in the nation for 14 consecutive years. By giving full play of bilateral advantages in product R&D and clinical areas, this partnership will help promote innovation and development to provide safe, effective and affordable high-end product and quality service for patients.

About MicroPort®

MicroPort Scientific Corporation (the "Group") is a leading medical device company with business focusing on innovating, manufacturing, and marketing high-quality and high-end medical devices globally. With a diverse portfolio of products now being used at an average rate of one for every 12 seconds in thousands of major hospitals around the world, the Group maintains world-wide operations in a broad range of business segments including Cardiovascular, Orthopedic, Cardiac Rhythm Management, Electrophysiological, Endovascular, Neurovascular, Surgical, Diabetes Care and Endocrinal Management, and others. MicroPort® is dedicated to becoming a patient oriented global enterprise improve and reshape patient lives through application of innovative science and technology.

For more information, please refer to: www.microport.com

Forward-Looking Statements

Some information contained on this website contains forward-looking statements. These forward-looking statements include, without limitation, those regarding our future financial position, our strategy, plans, objectives, goals and targets, future developments in the markets where we participate or are seeking to participate, and any statements preceded by, followed by or that include the words "believe", "intend", "expect", anticipate", "project", "estimate", "predict", "is confident", "has confidence" and similar expressions are also intended to identify forward-looking statements. Such statements are based upon the current beliefs and expectations of MicroPort®'s management and are subject to significant risks and uncertainties. MicroPort Scientific Corporation undertakes no obligation to update any of the statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors that could cause actual future results to differ materially from current expectations include, but are not limited to, general industry and economic conditions, PRC governmental policies and regulations relating to the medical device manufacturing industry, competition in the medical device manufacturing industry, our ability to develop new products and stay abreast of market trends and technological advances, our goals and strategies, our ability to execute strategic acquisitions of, investments in or alliances with other companies and businesses, fluctuations in general economic and business conditions in China.

This document is for information purposes only and does not constitute or form part of any offer or invitation to sell or the solicitation of an offer or invitation to purchase or subscribe for any securities of MicroPort Scientific Corporation, and no part of it shall form the basis of, or be relied upon in connection with, any agreement, arrangement, contract, commitment or investment decision in relation thereto whatsoever.

All rights reserved.
Copyright © 1998-2018 MicroPort Scientific Corporation

CONTACT:
Leanne Li
Board Secretary and Vice President of Corporate General Affairs
MicroPort Scientific Corporation
Tel: (86)(21) 38954600-6953
Email: ir@microport.com

 

[Prev]:Study Shows Patients with MicroPort®'s Medial-Pivot Knee Are More Likely to Forget They've Had a Joint Replacement (MicroPort®'s medial-pivot knee was designed to provide more stability and replicate the natural kinematics of the Knee)
[Next]:MicroPort® Attends the CCC2018